Erschienen in:
01.06.2012 | Editorial
Statins: a revised appraisal for potential additional future treatment indications
verfasst von:
Robert Weissert
Erschienen in:
Arthritis Research & Therapy
|
Ausgabe 3/2012
Einloggen, um Zugang zu erhalten
Abstract
Beside statins' well established positive influence on atherosclerotic vascular disease caused by hypercholesterolemia through selective competitive inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, additional effects on the immune system have been described for them. These observations have raised great hopes for additional future treatment indications, including rheumatoid arthritis and multiple sclerosis. Ten years of searching for such novel treatment indications have not led to breakthroughs and future efforts must be seen with skepticism.